- Horizon supplies genetically-defined cell lines, in vivo models, reference standards & contract research services to academia & biopharma
- Dan Cowell, Chris Torrance
- Biopharma, Biotechnology, Health Diagnostics
About Horizon Discovery Group plc www.horizondiscovery.com/
Horizon Discovery Group plc (LSE: HZD) ("Horizon"), is a world-leading gene editing company that designs and engineers genetically-modified cells and then applies them in research and clinical applications that advance human health.
Horizon’s core capabilities are built around its proprietary translational genomics platform, a highly precise and flexible suite of gene editing tools (rAAV, ZFN and CRISPR) able to alter almost any gene sequence in human or mammalian cell-lines.
Horizon offers over 23,000 catalogue products and related research services, almost all of which are based on the generation and application of cell and in vivo models that accurately recapitulate the disease-causing genetic anomalies found in diseases like cancer. Horizon’s commercial offering has been adopted by c1,400 unique research organisations in over 50 countries as well as in the Company’s own R&D pipeline to support a greater understanding of the genetic drivers of disease and the development of molecular, cell and gene therapies that can be prescribed on a personalised basis.
Horizon is headquartered in Cambridge, UK, and is listed on the London Stock Exchange’s AIM market under the ticker “HZD”.
Funding Rounds (5) - $50.25MUpdate
Current Team (13)Update
Board Members and Advisors (4)Update
|Sep 20, 2016||This is Money - FTSE LIVE: Footsie eases after jump with US and Asian stocks nervous ahead of key bank meetings|
|Jun 22, 2016||PRWeb Sitemap - Abcam Webinar Addresses Raising Antibody Validation Standards with Knockout Technology|
|May 12, 2016||This is Money - MARKET REPORT: Rank Group reports a full house of revenue growth as its casinos coin it in but punters are betting less on bingo|
|Mar 2, 2016||PRNewswire UK All - Global Specialty Contract Research Organizations (CROs) Market 2016 - Forecasts to 2025|
|Feb 26, 2016||Tech City Insider (London) - Disley keeps discovery on the horizon|
|Feb 18, 2016||This is Money - MARKET REPORT: Indivior stock is highly addictive as net income exceeds expectations|
|Feb 5, 2016||Business Wire India - Grapeshot Secures Major Funding with New Investor Draper Esprit|
|Feb 3, 2016||PE HUB - Grapeshot raises $8.5 mln|
7100 Cambridge Research Park
Cambridge, CB25 9TL